Exploration and management of adrenal incidentalomas.
Tóm tắt
Từ khóa
Tài liệu tham khảo
Grumbach, 2003, Management of the clinically inapparent adrenal mass (“incidentaloma”), Ann Intern Med, 138, 42, 10.7326/0003-4819-138-5-200303040-00013
Barzon, 2003, Prevalence and natural history of adrenal incidentalomas, Eur J Endocrinol, 149, 273, 10.1530/eje.0.1490273
Benitah, 2005, Minor morphologic abnormalities of adrenal glands at CT: prognostic importance in patients with lung cancer, Radiology, 235, 517, 10.1148/radiol.2352031708
Kloos, 1995, Incidentally discovered adrenal masses, Endocr Rev, 16, 460
Mansmann, 2004, The clinically inapparent adrenal mass: update in diagnosis and management, Endocr Rev, 25, 309, 10.1210/er.2002-0031
Mantero, 2000, A survey on adrenal incidentaloma in Italy, J Clin Endocrinol Metab, 85, 637
Bulow, 2002, Adrenal incidentaloma--experience of a standardized diagnostic programme in the Swedish prospective study, J Intern Med, 252, 239, 10.1046/j.1365-2796.2002.01028.x
Herrera, 1991, Incidentally discovered adrenal tumors: an institutional perspective, Surgery, 110, 1014
Francis, 1988, Adrenal masses in oncologic patients: functional and morphologic evaluation, Radiology, 166, 353, 10.1148/radiology.166.2.3336710
Lee, 1998, Unknown primary cancer presenting as an adrenal mass: frequency and implications for diagnostic evaluation of adrenal incidentalomas, Surgery, 124, 1115, 10.1067/msy.1998.92009
Blake, 2006, Distinguishing benign from malignant adrenal masses: multi-detector row CT protocol with 10-minute delay, Radiology, 238, 578, 10.1148/radiol.2382041514
Hahn, 2006, Adrenal lesions: attenuation measurement differences between CT scanners, Radiology, 240, 458, 10.1148/radiol.2402042120
Lee, 1991, Benign and malignant adrenal masses: CT distinction with attenuation coefficients, size, and observer analysis, Radiology, 179, 415, 10.1148/radiology.179.2.2014283
van Erkel, 1994, CT and MR distinction of adenomas and nonadenomas of the adrenal gland, J Comput Assist Tomogr, 18, 432, 10.1097/00004728-199405000-00017
Miyake, 1995, Adrenal nonhyperfunctioning adenoma and nonadenoma: CT attenuation value as discriminative index, Abdom Imaging, 20, 559, 10.1007/BF01256711
McNicholas, 1995, An imaging algorithm for the differential diagnosis of adrenal adenomas and metastases, AJR Am J Roentgenol, 165, 1453, 10.2214/ajr.165.6.7484585
Korobkin, 1996, Delayed enhanced CT for differentiation of benign from malignant adrenal masses, Radiology, 200, 737, 10.1148/radiology.200.3.8756924
Outwater, 1996, Adrenal masses: correlation between CT attenuation value and chemical shift ratio at MR imaging with in-phase and opposed-phase sequences, Radiology, 200, 749, 10.1148/radiology.200.3.8756926
Szolar, 1997, Quantitative CT evaluation of adrenal gland masses: a step forward in the differentiation between adenomas and nonadenomas?, Radiology, 202, 517, 10.1148/radiology.202.2.9015083
Boland, 1997, Adrenal masses: characterization with delayed contrast-enhanced CT, Radiology, 202, 693, 10.1148/radiology.202.3.9051018
Hamrahian, 2005, Clinical utility of noncontrast computed tomography attenuation value (hounsfield units) to differentiate adrenal adenomas/hyperplasias from nonadenomas: Cleveland Clinic experience, J Clin Endocrinol Metab, 90, 871, 10.1210/jc.2004-1627
Boland, 1998, Characterization of adrenal masses using unenhanced CT: an analysis of the CT literature, AJR Am J Roentgenol, 171, 201, 10.2214/ajr.171.1.9648789
Caoili, 2000, Delayed enhanced CT of lipid-poor adrenal adenomas, AJR Am J Roentgenol, 175, 1411, 10.2214/ajr.175.5.1751411
Caoili, 2002, Adrenal masses: characterization with combined unenhanced and delayed enhanced CT, Radiology, 222, 629, 10.1148/radiol.2223010766
Pena, 2000, Characterization of indeterminate (lipid-poor) adrenal masses: use of washout characteristics at contrast-enhanced CT, Radiology, 217, 798, 10.1148/radiology.217.3.r00dc29798
Szolar, 2005, Adrenocortical carcinomas and adrenal pheochromocytomas: mass and enhancement loss evaluation at delayed contrast-enhanced CT, Radiology, 234, 479, 10.1148/radiol.2342031876
Ramsay, 1987, Lipid degeneration in pheochromocytomas mimicking adrenal cortical tumors, Am J Surg Pathol, 11, 480, 10.1097/00000478-198706000-00009
Blake, 2003, Low-density pheochromocytoma on CT: a mimicker of adrenal adenoma, AJR Am J Roentgenol, 181, 1663, 10.2214/ajr.181.6.1811663
Fujiyoshi, 2003, Characterization of adrenal tumors by chemical shift fast low-angle shot MR imaging: comparison of four methods of quantitative evaluation, AJR Am J Roentgenol, 180, 1649, 10.2214/ajr.180.6.1801649
Rescinito, 2006, Characterization of adrenal adenomas and metastases: correlation between unenhanced computed tomography and chemical shift magnetic resonance imaging, Acta Radiol, 47, 71, 10.1080/02841850500405193
Mayo-Smith, 1995, Characterization of adrenal masses (<5cm) by use of chemical shift MR imaging: observer performance versus quantitative measures, AJR Am J Roentgenol, 165, 91, 10.2214/ajr.165.1.7785642
Outwater, 1994, Differentiation of adrenal masses with chemical shift MR imaging, Radiology, 193, 877, 10.1148/radiology.193.3.7972841
Israel, 2004, Comparison of unenhanced CT and chemical shift MRI in evaluating lipid-rich adrenal adenomas, AJR Am J Roentgenol, 183, 215, 10.2214/ajr.183.1.1830215
Korobkin, 1995, Characterization of adrenal masses with chemical shift and gadolinium-enhanced MR imaging, Radiology, 197, 411, 10.1148/radiology.197.2.7480685
Bilbey, 1995, MR imaging of adrenal masses: value of chemical-shift imaging for distinguishing adenomas from other tumors, AJR Am J Roentgenol, 164, 637, 10.2214/ajr.164.3.7863885
Outwater, 1995, Distinction between benign and malignant adrenal masses: value of T1-weighted chemical-shift MR imaging, AJR Am J Roentgenol, 165, 579, 10.2214/ajr.165.3.7645474
Reinig, 1994, Differentiation of adrenal masses with MR imaging: comparison of techniques, Radiology, 192, 41, 10.1148/radiology.192.1.8208962
Korobkin, 1996, Adrenal adenomas: relationship between histologic lipid and CT and MR findings, Radiology, 200, 743, 10.1148/radiology.200.3.8756925
Haider, 2004, Chemical shift MR imaging of hyperattenuating (>10HU) adrenal masses: does it still have a role?, Radiology, 231, 711, 10.1148/radiol.2313030676
Silverman, 1993, Predictive value of image-guided adrenal biopsy: analysis of results of 101 biopsies, Radiology, 187, 715, 10.1148/radiology.187.3.8497619
Al-Hawary, 2005, Non-invasive evaluation of the incidentally detected indeterminate adrenal mass, Best Pract Res Clin Endocrinol Metab, 19, 277, 10.1016/j.beem.2004.09.002
Dunnick, 2002, Imaging of adrenal incidentalomas: current status, AJR Am J Roentgenol, 179, 559, 10.2214/ajr.179.3.1790559
Schteingart, 2005, Management of patients with adrenal cancer: recommendations of an international consensus conference, Endocr Relat Cancer, 12, 667, 10.1677/erc.1.01029
Luton, 2000, Outcome in patients with adrenal incidentaloma selected for surgery: an analysis of 88 cases investigated in a single clinical center, Eur J Endocrinol, 143, 111, 10.1530/eje.0.1430111
Plouin, 2006, Initial work-up and long-term follow-up in patients with phaeochromocytomas and paragangliomas, Best Pract Res Clin Endocrinol Metab, 20, 421, 10.1016/j.beem.2006.07.004
Unger, 2006, Diagnostic value of various biochemical parameters for the diagnosis of pheochromocytoma in patients with adrenal mass, Eur J Endocrinol, 154, 409, 10.1530/eje.1.02097
Huizenga, 1998, Interperson variability but intraperson stability of baseline plasma cortisol concentrations, and its relation to feedback sensitivity of the hypothalamo-pituitary-adrenal axis to a low dose of dexamethasone in elderly individuals, J Clin Endocrinol Metab, 83, 47
Viardot, 2005, Reproducibility of nighttime salivary cortisol and its use in the diagnosis of hypercortisolism compared with urinary free cortisol and overnight dexamethasone suppression test, J Clin Endocrinol Metab, 90, 5730, 10.1210/jc.2004-2264
Catargi, 2003, Occult Cushing's syndrome in type-2 diabetes, J Clin Endocrinol Metab, 88, 5808, 10.1210/jc.2003-030254
Nieman, 2005, Evaluation and treatment of Cushing's syndrome, Am J Med, 118, 1340, 10.1016/j.amjmed.2005.01.059
Mattsson, 2006, Primary aldosteronism: diagnostic and treatment strategies, Nat Clin Pract Nephrol, 2, 198, 10.1038/ncpneph0151
Abiven, 2006, Clinical and biological features in the prognosis of adrenocortical cancer: poor outcome of cortisol-secreting tumors in a series of 202 consecutive patients, J Clin Endocrinol Metab, 91, 2650, 10.1210/jc.2005-2730
Ravichandran, 1996, Congenital adrenal hyperplasia presenting as massive adrenal incidentalomas in the sixth decade of life: report of two patients with 21-hydroxylase deficiency, J Clin Endocrinol Metab, 81, 1776
Seppel, 1994, Augmented 17 alpha-hydroxyprogesterone response to ACTH stimulation as evidence of decreased 21-hydroxylase activity in patients with incidentally discovered adrenal tumours (‘incidentalomas’), Clin Endocrinol (Oxf), 41, 445, 10.1111/j.1365-2265.1994.tb02575.x
Christopoulos, 2005, Clinical and subclinical ACTH-independent macronodular adrenal hyperplasia and aberrant hormone receptors, Horm Res, 64, 119, 10.1159/000088818
Shapiro B, Gross MD. Radioiodinated MIBG for the diagnostic scintigraphy and internal radiotherapy of neuroendocrine tumors. In: Modena, Arcadia: Ed L Troncone; 1991:65–94.
Lumachi, 2006, Sensitivity and positive predictive value of CT, MRI and 123I-MIBG scintigraphy in localizing pheochromocytomas: a prospective study, Nucl Med Commun, 27, 583, 10.1097/00006231-200607000-00006
Van Der Horst-Schrivers, 2006, Iodine-123 metaiodobenzylguanidine scintigraphy in localising phaeochromocytomas-experience and meta-analysis, Anticancer Res, 26, 1599
53 IP, 2004
Gross, 1988, Distinguishing benign from malignant euadrenal masses, Ann Intern Med, 109, 613, 10.7326/0003-4819-109-8-613
Gross, 1994, Scintigraphic evaluation of clinically silent adrenal masses, J Nucl Med, 35, 1145
Barzon, 1998, Incidentally discovered adrenal tumors: endocrine and scintigraphic correlates, J Clin Endocrinol Metab, 83, 55
Barzon, 2001, Scintigraphic patterns of adrenocortical carcinoma: morpho-functional correlates, Eur J Endocrinol, 145, 743, 10.1530/eje.0.1450743
Bardet, 1996, 131I-6 beta-iodomethylnorcholesterol scintigraphy: an assessment of its role in the investigation of adrenocortical incidentalomas, Clin Endocrinol (Oxf), 44, 587, 10.1046/j.1365-2265.1996.720541.x
Valli, 2001, Biochemical screening for subclinical cortisol-secreting adenomas amongst adrenal incidentalomas, Eur J Endocrinol, 144, 401, 10.1530/eje.0.1440401
Barzon, 2002, Development of overt Cushing's syndrome in patients with adrenal incidentaloma, Eur J Endocrinol, 146, 61, 10.1530/eje.0.1460061
Barzon, 1999, Risk factors and long-term follow-up of adrenal incidentalomas, J Clin Endocrinol Metab, 84, 520
Boland, 1995, Indeterminate adrenal mass in patients with cancer: evaluation at PET with 2-[F-18]-fluoro-2-deoxy-d-glucose, Radiology, 194, 131, 10.1148/radiology.194.1.7997539
Erasmus, 1997, Evaluation of adrenal masses in patients with bronchogenic carcinoma using 18F-fluorodeoxyglucose positron emission tomography, AJR Am J Roentgenol, 168, 1357, 10.2214/ajr.168.5.9129444
Yun, 2001, 18F-FDG PET in characterizing adrenal lesions detected on CT or MRI, J Nucl Med, 42, 1795
Blake, 2006, Adrenal lesions: characterization with fused PET/CT image in patients with proved or suspected malignancy-initial experience, Radiology, 238, 970, 10.1148/radiol.2383042164
Jana, 2006, FDG-PET and CT characterization of adrenal lesions in cancer patients, Eur J Nucl Med Mol Imaging, 33, 29, 10.1007/s00259-005-1915-8
Metser, 2006, 18F-FDG PET/CT in the evaluation of adrenal masses, J Nucl Med, 47, 32
Maurea, 2001, The diagnostic role of radionuclide imaging in evaluation of patients with nonhypersecreting adrenal masses, J Nucl Med, 42, 884
Tenenbaum, 2004, 18F-fluorodeoxyglucose positron emission tomography as a diagnostic tool for malignancy of adrenocortical tumours? Preliminary results in 13 consecutive patients, Eur J Endocrinol, 150, 789, 10.1530/eje.0.1500789
Shimizu, 2003, High [18F] 2-fluoro-2-deoxy-d-glucose (FDG) uptake of adrenocortical adenoma showing subclinical Cushing's syndrome, Ann Nucl Med, 17, 403, 10.1007/BF03006609
Rao, 2004, F-18 fluorodeoxyglucose positron emission tomography-positive benign adrenal cortical adenoma: imaging features and pathologic correlation, Clin Nucl Med, 29, 300, 10.1097/01.rlu.0000124008.68606.4c
Ludwig, 2002, 2-Deoxy-2-[18F]fluoro-d-glucose positron emission tomography uptake in a giant adrenal myelolipoma, Mol Imaging Biol, 4, 355, 10.1016/S1536-1632(02)00018-5
Lin, 2002, Adrenal hyperplasia in Cushing's syndrome demonstrated by FDG positron emission tomographic imaging, Clin Nucl Med, 27, 516, 10.1097/00003072-200207000-00010
Terzolo, 2005, Subclinical Cushing's syndrome in adrenal incidentalomas, Endocrinol Metab Clin North Am, 34, 423, 10.1016/j.ecl.2005.01.008
Tsagarakis, 1998, The low-dose dexamethasone suppression test in patients with adrenal incidentalomas: comparisons with clinically euadrenal subjects and patients with Cushing's syndrome, Clin Endocrinol (Oxf), 48, 627, 10.1046/j.1365-2265.1998.00464.x
Rossi, 2000, Subclinical Cushing's syndrome in patients with adrenal incidentaloma: clinical and biochemical features, J Clin Endocrinol Metab, 85, 1440
Bernini, 2005, Long-term morphological and hormonal follow-up in a single unit on 115 patients with adrenal incidentalomas, Br J Cancer, 92, 1104, 10.1038/sj.bjc.6602459
Garrapa, 2001, Body composition and metabolic features in women with adrenal incidentaloma or Cushing's syndrome, J Clin Endocrinol Metab, 86, 5301
Fernandez-Real, 1998, Study of glucose tolerance in consecutive patients harbouring incidental adrenal tumours, Clin Endocrinol (Oxf), 49, 53, 10.1046/j.1365-2265.1998.00437.x
Tabarin A, Enfer-Vattaut S, Latrabe V. Incidentalomes Surrénaliens. Med Clin Endocrinol Diab 2006;Hors Série:11–20.
Reincke, 1992, Preclinical Cushing's syndrome in adrenal “incidentalomas”: comparison with adrenal Cushing's syndrome, J Clin Endocrinol Metab, 75, 826
Erbil, 2006, Evaluation of the cardiovascular risk in patients with subclinical Cushing syndrome before and after surgery, World J Surg, 30, 1665, 10.1007/s00268-005-0681-x
Reincke, 2000, Subclinical Cushing's syndrome, Endocrinol Metab Clin North Am, 29, 43, 10.1016/S0889-8529(05)70115-8
Tauchmanova, 2002, Patients with subclinical Cushing's syndrome due to adrenal adenoma have increased cardiovascular risk, J Clin Endocrinol Metab, 87, 4872, 10.1210/jc.2001-011766
Terzolo, 2002, Adrenal incidentaloma: a new cause of the metabolic syndrome?, J Clin Endocrinol Metab, 87, 998, 10.1210/jcem.87.3.8277
Midorikawa, 2001, The improvement of insulin resistance in patients with adrenal incidentaloma by surgical resection, Clin Endocrinol (Oxf), 54, 797, 10.1046/j.1365-2265.2001.01274.x
Bernini, 2003, Anthropometric, haemodynamic, humoral and hormonal evaluation in patients with incidental adrenocortical adenomas before and after surgery, Eur J Endocrinol, 148, 213, 10.1530/eje.0.1480213
Lifante, 2005, Impact of laparoscopy on the management of adrenal diseases. A retrospective study of 220 patients, Ann Chir, 130, 547, 10.1016/j.anchir.2005.03.011
Krane, 1986, Clinically unsuspected pheochromocytomas. Experience at Henry Ford Hospital and a review of the literature, Arch Intern Med, 146, 54, 10.1001/archinte.1986.00360130064008
Voros, 1996, Undiagnosed phaeochromocytomas in the perioperative period, Eur J Surg, 162, 985
Thompson, 1997, Laparoscopic versus open posterior adrenalectomy: a case-control study of 100 patients, Surgery, 122, 1132, 10.1016/S0039-6060(97)90218-X
Modlin, 1979, Phaeochromocytomas in 72 patients: clinical and diagnostic features, treatment and long-term results, Br J Surg, 66, 456, 10.1002/bjs.1800660704
van Heerden, 1990, Long-term evaluation following resection of apparently benign pheochromocytoma(s)/paraganglioma(s), World J Surg, 14, 325, 10.1007/BF01658516
Hamoir, 1998, Is laparoscopic resection of a malignant corticoadrenaloma feasible? Case report of early, diffuse and massive peritoneal recurrence after attempted laparoscopic resection, Ann Chir, 52, 364
Iacconi, 1999, Re: A case of Cushing's syndrome due to adrenocortical carcinoma with recurrence 19 months after laparoscopic adrenalectomy. Re: Re: A case of Cushing's syndrome due to adrenocortical carcinoma with recurrence 19 months after laparoscopic adrenalectomy, J Urol, 161, 1580, 10.1016/S0022-5347(05)68968-9
Ushiyama, 1997, A case of Cushing's syndrome due to adrenocortical carcinoma with recurrence 19 months after laparoscopic adrenalectomy, J Urol, 157, 2239, 10.1016/S0022-5347(01)64729-3
Deckers, 1999, Peritoneal carcinomatosis following laparoscopic resection of an adrenocortical tumor causing primary hyperaldosteronism, Horm Res, 52, 97, 10.1159/000023442
Cobb, 2005, Laparoscopic adrenalectomy for malignancy, Am J Surg, 189, 405, 10.1016/j.amjsurg.2005.01.021
Moinzadeh, 2005, Laparoscopic radical adrenalectomy for malignancy in 31 patients, J Urol, 173, 519, 10.1097/01.ju.0000149038.89467.30
Chan, 2006, Prospective comparison of early and late experience with laparoscopic adrenalectomy, Am J Surg, 191, 682, 10.1016/j.amjsurg.2006.01.042
Gumbs, 2006, Laparoscopic adrenalectomy, Best Pract Res Clin Endocrinol Metab, 20, 483, 10.1016/j.beem.2006.07.010
Henry, 2000, Complications of laparoscopic adrenalectomy: results of 169 consecutive procedures, World J Surg, 24, 1342, 10.1007/s002680010222
Ting, 1998, Posterior or laparoscopic approach for adrenalectomy, Am J Surg, 175, 488, 10.1016/S0002-9610(98)00081-6
Palazzo, 2006, Long-term outcome following laparoscopic adrenalectomy for large solid adrenal cortex tumors, World J Surg, 30, 893, 10.1007/s00268-005-0288-2
Hanssen, 2006, Safety and efficacy of endoscopic retroperitoneal adrenalectomy, Br J Surg, 93, 715, 10.1002/bjs.5337
Bulow, 2006, Adrenal incidentaloma - follow-up results from a Swedish prospective study, Eur J Endocrinol, 154, 419, 10.1530/eje.1.02110
Libe, 2002, Long-term follow-up study of patients with adrenal incidentalomas, Eur J Endocrinol, 147, 489, 10.1530/eje.0.1470489
Libe, 2006, A primary adrenal non-Hodgkin's lymphoma presenting as an incidental adrenal mass, Exp Clin Endocrinol Diabetes, 114, 140, 10.1055/s-2005-865913